Safety and clinical usage of newcastle disease virus in cancer therapy

HIGHLIGHTS

• who: Cancer Therapy and colleagues from the Universiti Putra Malaysia have published the paper: Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy, in the Journal: (JOURNAL) of 29/06/2011
• what: The focus of this paper relates to the safety and preclininal/clinical experiences of utilizing NDV strains in cancer treatment. With a two-year followup, the analysis showed that only 10 relapses (18%) among the patients, along with a median followup of 39 months.
• how: Some of the studies have undergone human clinical trials and favorable results were obtained . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.